Rankings
▼
Calendar
ARVN Q3 2023 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$907M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$35M
+4.2% YoY
Gross Profit
$33M
95.1% margin
Operating Income
-$74M
-213.6% margin
Net Income
-$64M
-185.0% margin
EPS (Diluted)
$-1.18
QoQ Revenue Growth
-36.5%
Cash Flow
Operating Cash Flow
-$85M
Free Cash Flow
-$86M
Stock-Based Comp.
$17M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$601M
Stockholders' Equity
$457M
Cash & Equivalents
$114M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$35M
$33M
+4.2%
Gross Profit
$33M
$31M
+5.8%
Operating Income
-$74M
-$64M
-14.9%
Net Income
-$64M
-$66M
+3.3%
← FY 2023
All Quarters
Q4 2023 →